Germany
Japan
United Kingdom
China
Primary Antibodies
View as table Download
HLA Class II DR mouse monoclonal antibody, clone L243, Purified
| Applications | FC, FN, IF, IHC, IP, WB |
| Reactivities | Canine, Human, Primate |
| Conjugation | Unconjugated |
Rabbit Polyclonal Antibody against ATG5
| Applications | Electron Microscopy, ELISA, FC, ICC/IF, IHC, Immunoblotting, IP, Simple Western, WB |
| Reactivities | Human, Mouse, Porcine, Primate, Xenopus, Zebrafish, Cow, Rat |
| Conjugation | Unconjugated |
| Immunogen | A synthetic peptide made to an N-terminal region (within residues 1-50) of the human ATG5 protein. [Swiss-Prot# Q9H1Y0] |
CD61 (ITGB3) mouse monoclonal antibody, clone VIPL2, Aff - Purified
| Applications | FC, IHC, WB |
| Reactivities | Human, Primate |
| Conjugation | Unconjugated |
USD 410.00
2 Weeks
Complement C5 (C5) (neoepitope) mouse monoclonal antibody, clone HCC5b.1 (neo), Purified
| Applications | ELISA, IHC, WB |
| Reactivities | Bovine, Goat, Human, Porcine, Primate |
| Conjugation | Unconjugated |
Rabbit Polyclonal Antibody against TARDBP
| Applications | ELISA, ICC/IF, IHC, WB |
| Reactivities | Human, Primate, Mouse, Xenopus, Zebrafish, Chicken |
| Conjugation | Unconjugated |
| Immunogen | A synthetic peptide to a C-terminal region [within residues 350-414] of the human TARDBP protein. [Swiss-Prot# Q13148] |
p53 (TP53) (16-25) mouse monoclonal antibody, clone BP53-12, Purified
| Applications | ELISA, IF, IHC, IP, WB |
| Reactivities | Human, Primate |
| Conjugation | Unconjugated |
Mouse Monoclonal Aurora A Antibody (1F8)
| Applications | ELISA, FC, ICC/IF, WB |
| Reactivities | Human, Rat, Primate |
| Conjugation | Unconjugated |
TA336917 is a replacement of AM06572SU-N.
Active filters
Filter by
Target Symbol
Antibody Hosts
Clonalities
Conjugates
Assay Types
Families
Pathways
- Focal adhesion (3)
- Regulation of actin cytoskeleton (3)
- Wnt signaling pathway (3)
- Adherens junction (2)
- Alzheimer's disease (2)
- Apoptosis (2)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (2)
- Cell cycle (2)
- Dilated cardiomyopathy (2)
- Hematopoietic cell lineage (2)
- Huntington's disease (2)
- Hypertrophic cardiomyopathy (HCM) (2)
- Leukocyte transendothelial migration (2)
- MAPK signaling pathway (2)
- Pathogenic Escherichia coli infection (2)
- Pathways in cancer (2)
- Prion diseases (2)
- Prostate cancer (2)
- TGF-beta signaling pathway (2)
- ABC transporters (1)
- Amyotrophic lateral sclerosis (ALS) (1)
- Axon guidance (1)
- Basal cell carcinoma (1)
- Base excision repair (1)
- Bladder cancer (1)
- Chemokine signaling pathway (1)
- Chronic myeloid leukemia (1)
- Colorectal cancer (1)
- Complement and coagulation cascades (1)
- Cytokine-cytokine receptor interaction (1)
- Cytosolic DNA-sensing pathway (1)
- ECM-receptor interaction (1)
- Endometrial cancer (1)
- Glioma (1)
- Glycolysis / Gluconeogenesis (1)
- Graft-versus-host disease (1)
- Jak-STAT signaling pathway (1)
- Long-term potentiation (1)
- Melanogenesis (1)
- Melanoma (1)
- Metabolic pathways (1)
- NOD-like receptor signaling pathway (1)
- Neurotrophin signaling pathway (1)
- Non-small cell lung cancer (1)
- Notch signaling pathway (1)
- Oocyte meiosis (1)
- Pancreatic cancer (1)
- RIG-I-like receptor signaling pathway (1)
- Regulation of autophagy (1)
- Renal cell carcinoma (1)
- Small cell lung cancer (1)
- Systemic lupus erythematosus (1)
- Thyroid cancer (1)
- Tight junction (1)
- Toll-like receptor signaling pathway (1)
- Type I diabetes mellitus (1)
- Vascular smooth muscle contraction (1)
- Vibrio cholerae infection (1)
- Viral myocarditis (1)
- p53 signaling pathway (1)